期刊文献+

铜绿假单胞菌临床分离株的耐药性分析 被引量:3

Drug-resistance of Pseudomonas aeruginosa Isolated from Patients in Hospital
原文传递
导出
摘要 目的分析2006年1月-2008年12月医院痰液中分离的铜绿假单胞菌耐药性与耐药趋势,为临床预防感染以及合理用药提供依据。方法采集来自各临床科室送检的痰标本,采用美国VITEK-32自动微生物分析仪进行细菌学培养鉴定及药敏试验。结果196株铜绿假单胞菌对16种抗菌药物中对头孢哌酮/舒巴坦、哌拉西林/他唑巴坦、亚胺培南、奈替米星的耐药率为18.37%、16.84%、18.88%、17.35%,而耐药率最高的是复方新诺明(100.00%)、氨苄西林(99.49%)、头孢唑林(99.49%)、头孢替坦(88.78%)、头孢曲松(79.08%);头孢类抗菌药物耐药率有上升趋势,哌拉西林/他唑巴坦和替卡西林/克拉维酸耐药率有下降趋势。结论铜绿假单胞菌单一及多药耐药情况均较严重,对β-内酰胺酶抑制剂复合药物、氨基糖苷类保持较好的敏感性,根据药敏结果合理使用抗菌药物是延缓其耐药株快速升高的最好办法。 OBJECTIVE To investigate the change of antibiotics resistance of the Pseudomonas aeruginosa isolated from patients′s sputum in our hospital from Jan 2006 to Dec 2008,and offer basis for prevention of clinical infection and the reasonable use of drugs.METHODS The culture,identification and sensitivity to antibiotics of P.aeruginosa from the clinical sputum specimens were analyzed using USA VITEK-32 system.RESULTS Totally 196 strains of P.aeruginosa were isolated and characterized during the three years.The rates of resistance to cefoperazone/sulbactam were 18.37%,piperacillin/tazobactam 16.84%,netilmicin 17.35%,trimethoprim/sulfamesoxazole 100.00%,ampicillin 99.49%,cefazolin 99.49%,cefotetan 88.78%,and to ceftriaxone were 79.08%.The resistance rate to cephalosporins showed rising tendency.But the resistance rate to β-lactam antibiotics showed deereasing tendency.CONCLUSIONS P.aeruginosa has single and multi-resistance to antibiotics seriously,but sensitive to β-lactam antibiotics and aminoglycosides.Using antibiotics reasonably based on bacteria identification and sensitivity test is the best way to reduce the resistance of the pathogens.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第23期3261-3262,共2页 Chinese Journal of Nosocomiology
关键词 铜绿假单胞菌 耐药性 抗菌药物 Pseudomonas aeruginosa Drug-resistance Antibiotics
  • 相关文献

参考文献3

二级参考文献32

共引文献113

同被引文献32

  • 1冯霞,林红燕,杨俊何,魏衍超,张春梅.铜绿假单孢菌耐药性与广谱抗菌药物消耗量相关性研究[J].中国医院用药评价与分析,2006,6(3):159-162. 被引量:26
  • 2于勇.病原菌耐药与抗菌药物使用的宏观量化关系[J].微生物学通报,2006,33(4):186-189. 被引量:14
  • 3Paterson DL, The epidemiological profile of infectionswith multidrug-resistant Pseudomonas aeruginosa and acinetobacter species[J].Clin Infect Dis, 2006, 43(suppl 2) : S43.
  • 4Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance[J]. Clin Microbiol Infect, 2005,11(Suppl 5): 4.
  • 5Troillet N, Samore MH, Carmeli Y, el resistant Pseudomonas aeruginosa: al. Imipenem-- risk factors and antibi-- otic susceptibility patterns[J]. Chin Infect Dis, 1997, 25. 1094.
  • 6Cizman M, Srovin T, Pokorn M, et al. Analysis of the causes and consequences of decreased antibioticconsumption over the last 5 years in Slovenia[J]. J AntimicrobialChemotherapy, 2005, 55(5): 758.
  • 7Gruson D, Hilbert G, Vargas F, et al. Strategy of antibi- otic rotation." long-term effect on incidence and SUS ceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumoni[J].Crit Care Meal, 2003 31(7): 1908.
  • 8Wiesner J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system[J]. Virulence, 2010, 1(5): 440-464.
  • 9Guani Guerra E, Santos-Mendoza T, Lugo-Reyes S O, et al. Antimicrobial peptides: general overview and clin- ical implications in human health and disease[J]. Clin Im- munol, 2010, 135(1): 1-11.
  • 10Lapis K. Physiologic and pathophysiologic significance of antimicrobial (host defensive) small peptides[J]. Orv Hetil, 2008, 149(51): 2419-2424.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部